[Sponsored] A Closer Look at Systemic Mastocytosis (Webinar)

We thank Blueprint Medicines for their sponsorship of this blog post to help us share information for people managing systemic mastocytosis (SM). This is a sponsored post and is not an endorsement of any company or its products, nor is it a guarantee of any product’s safety. The funding we received for this advertisement helps support our free asthma and allergy programs. Systemic mastocytosis (SM) affects nearly 32,000 people in the United States. People with SM have too many abnormal mast…

Lesen Sie weiter auf: [Sponsored] A Closer Look at Systemic Mastocytosis (Webinar)
Quelle: Asthma and Allergy Foundation of America
Titelbild/Grafik by Asthma and Allergy Foundation of America (AAFA)

Kommentare und Fragen

Möchten Sie zu diesem Artikel ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!

Weiteres von Asthma and Allergy Foundation of America

• TEZSPIRE Approved for Self-Administration in the US With a New Pre-Filled Pen
• Webinar: Asthma and the “Tripledemic” (Flu, COVID-19, and RSV)
• Improving Care for School Children in Communities at High Risk for Asthma Disparities
• Asthma and Allergy Research Updates - January 2023
• FDA Approves Under-the-Tongue Allergen Tablet to Treat Dust Mite Allergy in Children Ages 12-17
• Gifts to Give People With Asthma and Allergies
• FDA Accepts Application for RSV Vaccine for Infants
• A New Look to Better Serve Families Living With Food Allergies
• Tree Pollen: Spring’s First Allergy Offender
• FDA Approves AIRSUPRA, a New Quick-Relief Medicine for Adults with Moderate-to-Severe Asthma